Derya Tilki

Derya Tilki's AcademicInfluence.com Rankings

Derya Tilki

Computer Science

#9850

World Rank

#10333

Historical Rank

Computer Engineering

#137

World Rank

#139

Historical Rank

Data Science

#245

World Rank

#250

Historical Rank

Computational Linguistics

#2434

World Rank

#2458

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Derya Tilki Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Derya Tilki's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020) (1179)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. (2020) (440)
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. (2019) (219)
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. (2009) (187)
Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. (2011) (182)
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. (2010) (176)
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model (2014) (168)
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort (2011) (158)
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy (2010) (147)
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). (2019) (121)
Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy (2011) (111)
Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron‐sparing surgery in patients with renal cell carcinoma (2009) (111)
Biomarkers in prostate cancer - Current clinical utility and future perspectives. (2017) (110)
Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. (2011) (108)
Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical Prostatectomy. (2016) (104)
Vascular wall as a reservoir for different types of stem and progenitor cells. (2011) (100)
Stage‐dependent increase of orosomucoid and zinc‐alpha2‐glycoprotein in urinary bladder cancer (2005) (98)
Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer (2004) (98)
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review. (2019) (95)
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. (2011) (92)
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations. (2020) (88)
18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent. (2013) (87)
Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL). (2013) (85)
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. (2020) (84)
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. (2014) (82)
Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. (2012) (81)
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. (2011) (81)
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. (2012) (79)
Emerging biology of vascular wall progenitor cells in health and disease. (2009) (77)
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer (2006) (76)
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. (2010) (76)
Predictors of cancer‐specific mortality after disease recurrence following radical cystectomy (2013) (75)
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. (2012) (75)
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study. (2017) (73)
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study. (2019) (73)
The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up. (2007) (72)
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. (2014) (71)
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy (2013) (70)
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. (2012) (69)
Plasma vaporisation of the prostate: initial clinical results. (2010) (68)
Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. (2019) (67)
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. (2010) (66)
Lymphadenectomy for bladder cancer at the time of radical cystectomy. (2013) (64)
Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer. (2011) (63)
Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? (2012) (62)
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. (2020) (62)
Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. (2011) (62)
Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer Prior to Initial Prostate Biopsy. (2019) (61)
A comparative study of robot‐assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures (2019) (61)
The effect of age on functional outcomes after radical prostatectomy. (2015) (60)
Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) (2014) (60)
Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy (2013) (60)
Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. (2013) (60)
Optimizing vesicourethral anastomosis healing after robot-assisted laparoscopic radical prostatectomy: lessons learned from three techniques in 1900 patients. (2010) (60)
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality (2019) (58)
Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy. (2015) (58)
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. (2013) (57)
Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen Receptor. (2016) (57)
Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis. (2007) (57)
The prognostic value of cadherin switch in bladder cancer. (2010) (56)
Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer. (2018) (55)
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. (2010) (55)
Vascular wall-resident stem cells. (2010) (55)
Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid--first clinical experiences. (2008) (54)
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy. (2017) (54)
CEACAM1: a novel urinary marker for bladder cancer detection. (2010) (53)
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment. (2017) (52)
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort. (2015) (50)
Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches. (2019) (48)
Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics (2019) (47)
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. (2017) (47)
Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy. (2015) (46)
Organ‐preserving neodymium‐yttrium‐aluminium‐garnet laser therapy for penile carcinoma: a long‐term follow‐up (2010) (46)
Endothelial and Hematopoietic Progenitor Cells (EPCs and HPCs): Hand in Hand Fate Determining Partners for Cancer Cells (2008) (46)
External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort. (2019) (46)
Postoperative complications of contemporary open and robot‐assisted laparoscopic radical prostatectomy using standardised reporting systems (2018) (45)
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. (2010) (43)
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer (2012) (43)
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria (2016) (43)
Potential implications of vascular wall resident endothelial progenitor cells (2007) (43)
Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery. (2019) (43)
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy (2017) (43)
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility. (2015) (42)
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab (2012) (41)
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. (2013) (41)
Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. (2007) (40)
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? (2018) (39)
Positive urine cytology but negative white‐light cystoscopy: an indication for fluorescence cystoscopy? (2009) (39)
Population‐Based Validation of the 2014 ISUP Gleason Grade Groups in Patients Treated With Radical Prostatectomy, Brachytherapy, External Beam Radiation, or no Local Treatment (2017) (39)
Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. (2012) (38)
The PolyScope: a modular design, semidisposable flexible ureterorenoscope system. (2010) (38)
Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center. (2017) (37)
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion (2018) (37)
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection. (2020) (37)
Local treatment for metastatic prostate cancer: A systematic review (2018) (37)
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. (2017) (36)
Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement (2009) (36)
The role of microRNA in castration-resistant prostate cancer. (2014) (35)
Zone‐specific remodeling of tumor blood vessels affects tumor growth (2007) (35)
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. (2022) (35)
In-hospital length of stay after major surgical oncological procedures. (2018) (34)
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline (2017) (34)
Preliminary evaluation of a novel side‐fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex‐vivo and in‐vivo investigations (2009) (33)
Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ‐confined prostate cancer (2019) (33)
Incidence, Risk Factors, Management, and Complications of Rectal Injuries During Radical Prostatectomy. (2017) (33)
Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages (2018) (33)
Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. (2015) (32)
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy (2010) (32)
Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey. (2018) (31)
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis. (2014) (31)
Multiparametric ultrasound for prostate cancer detection and localization: Correlation of B-mode, shearwave elastography and contrast-enhanced ultrasound with radical prostatectomy specimens. (2019) (31)
Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series (2010) (31)
Endothelial Effects of 3-Hydroxyglutaric Acid: Implications for Glutaric Aciduria Type I (2006) (31)
Implementation of Intraoperative Frozen Section During Radical Prostatectomy: Short-term Results from a German Tertiary-care Center. (2019) (30)
Tumor Characteristics and Oncologic Outcome after Radical Prostatectomy in Men 75 Years Old or Older. (2016) (30)
Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm H (2019) (30)
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review. (2020) (30)
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy (2013) (30)
Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. (2015) (29)
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death (2021) (28)
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. (2011) (28)
Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis. (2016) (28)
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy (2012) (28)
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival (2016) (28)
Rates of Positive Surgical Margins and Their Effect on Cancer‐specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer (2019) (27)
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. (2011) (27)
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series (2013) (27)
The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy. (2014) (26)
Predictors of Survival in Patients With Soft Tissue Surgical Margin Involvement at Radical Cystectomy (2013) (26)
Accuracy of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage Lymphadenectomy. (2020) (26)
Significance of vascular stabilization for tumor growth and metastasis. (2006) (26)
Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies (2018) (25)
Multiparametric ultrasound: evaluation of greyscale, shear wave elastography and contrast-enhanced ultrasound for prostate cancer detection and localization in correlation to radical prostatectomy specimens (2018) (25)
Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer. (2017) (25)
Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up. (2011) (25)
The complex structure of the smooth muscle layer of spermatic veins and its potential role in the development of varicocele testis. (2007) (25)
The Impact of Anxiety and Depression on Surgical and Functional Outcomes in Patients Who Underwent Radical Prostatectomy. (2020) (24)
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management (2016) (24)
The changing landscape of advanced and castration resistant prostate cancer: latest science and revised definitions. (2014) (24)
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in D'Amico Intermediate- and High- Risk Radical Prostatectomy Patients: A Multi-Institutional Study. (2019) (24)
Pro-angiogenic properties of orosomucoid (ORM). (2009) (24)
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder (2011) (24)
How can we expand active surveillance criteria in patients with low‐ and intermediate‐risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator (2018) (24)
In vitro investigations of repulsion during laser lithotripsy using a pendulum set-up (2012) (22)
Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years. (2018) (22)
[PDE5 inhibitors. A new option in the treatment of ureteral colic?]. (2007) (22)
Adjuvant cisplatin‐based combined chemotherapy for lymph node (LN)‐positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients (2015) (22)
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (2021) (21)
Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer. (2018) (21)
Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review. (2015) (21)
Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium. (2017) (21)
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now? (2019) (21)
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. (2019) (20)
Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial. (2019) (20)
Hereditary prostate cancer - Primetime for genetic testing? (2019) (20)
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research. (2021) (20)
EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer. (2014) (20)
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder (2011) (20)
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients (2018) (19)
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68 Ga-PSMA and 11 C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections (2020) (19)
Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups (2021) (19)
Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities. (2020) (19)
Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins (2017) (19)
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis. (2021) (19)
Expression of Small Non-coding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease. (2020) (19)
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy. (2021) (19)
Urinary cytology in era of fluorescence endoscopy: redefining the role of an established method with a new reference standard. (2010) (19)
Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database. (2019) (19)
Long‐term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence (2018) (18)
Surgical learning curve for open radical prostatectomy: Is there an end to the learning curve? (2015) (18)
Intermediate-differentiated invasive (pT1 G2) penile cancer--oncological outcome and follow-up. (2011) (18)
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks. (2013) (18)
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment (2017) (18)
Clinical Implications of the 2004 WHO Histological Classification on Non-Invasive Tumours of the Urinary Bladder (2006) (18)
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review. (2020) (18)
Timing of radiotherapy after radical prostatectomy (2020) (18)
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? (2012) (18)
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis (2017) (18)
[Imaging procedures to diagnose prostate cancer]. (2007) (17)
Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients. (2018) (17)
Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomy (2015) (17)
Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer (2018) (17)
Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review (2013) (17)
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study. (2021) (17)
Ho:YAG-laser: treatment of vesicourethral strictures after radical prostatectomy (2010) (17)
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. (2020) (17)
Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study. (2019) (17)
The role of lymphangiogenesis in lymphatic tumour spread of urological cancers (2009) (16)
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy. (2016) (16)
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer. (2021) (16)
Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma. (2020) (16)
Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery (2011) (16)
External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer. (2017) (16)
Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis? (2019) (15)
Introducing PIONEER: a project to harness big data in prostate cancer research (2020) (15)
Radical prostatectomy in patients aged 75 years or older: review of the literature (2017) (15)
Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer. (2016) (15)
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. (2012) (15)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database. (2018) (15)
Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies (2016) (15)
Impact of obesity on perioperative outcomes at robotic-assisted and open radical prostatectomy: results from the National Inpatient Sample. (2019) (14)
More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder (2019) (14)
The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis. (2019) (14)
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy (2018) (14)
The Impact of Lymph Node Metastases Burden at Radical Prostatectomy. (2018) (14)
Imaging modalities in synchronous oligometastatic prostate cancer (2018) (14)
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). (2018) (14)
Salvage therapy for prostate cancer after radical prostatectomy (2021) (14)
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis. (2020) (14)
[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]. (2011) (14)
Twenty‐year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort (2021) (13)
Individual learning curve reduces the clinical value of urinary cytology. (2011) (13)
Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem (2017) (13)
Increasing rates of NCCN high and very high‐risk prostate cancer versus number of prostate biopsy cores (2021) (13)
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer (2021) (13)
Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States (2018) (13)
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer. (2018) (13)
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. (2018) (13)
Additional androgen deprivation makes the difference (2015) (13)
[Fluorescence cystoscopy at bladder cancer: present trials]. (2007) (13)
Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomy (2019) (12)
Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent (2012) (12)
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy? (2020) (12)
Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy. (2020) (12)
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. (2019) (12)
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. (2022) (12)
Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer (2017) (12)
Centralization and Quality Control of Elective Surgery Improve Outcome: Aren't We Ethically Obliged to Force the Pace of Creating High-volume Centers? (2015) (12)
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study (2018) (12)
Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database. (2018) (12)
Radical prostatectomy after previous TUR-P: Oncological, surgical, and functional outcomes. (2018) (12)
Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation. (2021) (11)
Lymphatic reprogramming of micro vascular endothelial cells by CEA-related Cell Adhesion Molecule-1 via interaction with VEGFR-3 and Prox 1 (2007) (11)
PDE-5-Inhibitoren (2007) (11)
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells (2020) (11)
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression. (2017) (11)
[Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]. (2011) (11)
Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer. (2021) (11)
Bladder cancer: Nomogram aids clinical decision making after radical cystectomy (2010) (11)
The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer. (2020) (11)
Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram (2018) (11)
Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer. (2019) (11)
High level of endostatin in epididymal epithelium: protection against primary malignancies in this organ? (2008) (10)
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients (2018) (10)
Robotic-assisted vs. open radical prostatectomy: an update to the never-ending debate (2018) (10)
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates. (2019) (10)
Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. (2020) (10)
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center. (2021) (10)
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer (2021) (10)
Non‐cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy (2021) (10)
Incidence rates and contemporary trends in primary urethral cancer (2021) (10)
Optical coherence tomography (OCT): ready for the diagnosis of a nephrogenic adenoma of the urinary bladder? (2008) (10)
68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy: Central Review of Imaging and Comparison with Histopathology of Extended Lymphadenectomy. (2021) (10)
Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models. (2016) (10)
Differences between rural and urban prostate cancer patients (2020) (9)
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis. (2021) (9)
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals. (2017) (9)
1890 THE “ALL-SEEING NEEDLE“ – AN OPTICAL PUNCTURE SYSTEM CONFIRMING PERCUTANEOUS ACCESS IN PCNL (2010) (9)
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair (2020) (9)
Molecular imaging of tumor blood vessels in prostate cancer. (2009) (9)
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy (2016) (9)
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer (2022) (9)
Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. (2019) (9)
Insights from a whole cystectomy specimen--association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ. (2008) (9)
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer. (2019) (9)
Influence of clinical information on the interpretation of urinary cytology in bladder cancer: how suggestible is a cytologist? (2010) (9)
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy. (2021) (9)
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy (2021) (9)
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy. (2021) (8)
Impact of preoperative risk on metastatic progression and cancer‐specific mortality in patients with adverse pathology at radical prostatectomy (2017) (8)
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical Prostatectomy (2022) (8)
Current status of ultrasound imaging in prostate cancer. (2010) (8)
Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy (2021) (8)
Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities (2021) (8)
Minimum Number of MRI Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective Lesion-Based Analyses of Patients Treated with Radical Prostatectomy. (2020) (8)
Focal Therapy for Prostate Cancer: Complications and Their Treatment (2021) (8)
Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making (2021) (8)
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer. (2019) (8)
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups. (2020) (7)
The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer. (2016) (7)
Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection. (2018) (7)
Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens. (2020) (7)
Bladder cancer stage and mortality: urban vs. rural residency (2020) (7)
Poor Adherence to International Cancer Prevention Recommendations Among Patients With Prostate Cancer: First Results From the MARTINI-Lifestyle Cohort. (2020) (7)
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients (2021) (7)
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review. (2021) (7)
Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder. (2020) (7)
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy. (2019) (7)
[One molecule, two faces. Epithelial loss of cell adhesion molecule CEACAM1 activates angiogenesis in bladder and prostate cancer]. (2007) (7)
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients. (2019) (7)
Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy (2021) (7)
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. (2012) (7)
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. (2019) (6)
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study. (2020) (6)
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age (2019) (6)
Improving the Stratification of Patients With Intermediate-risk Prostate Cancer. (2020) (6)
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review (2022) (6)
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study (2019) (6)
Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer. (2020) (6)
Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: results of a prospective assessment (2019) (6)
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. (2021) (6)
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients (2019) (6)
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery. (2018) (6)
Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence. (2020) (6)
Impact of the estimated blood loss during radical prostatectomy on functional outcomes. (2019) (6)
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer (2020) (6)
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma. (2021) (6)
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study (2020) (6)
The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer. (2020) (5)
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center Experience. (2017) (5)
Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial (2018) (5)
Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI (2018) (5)
The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer. (2020) (5)
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy (2018) (5)
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis. (2021) (5)
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy (2022) (5)
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients. (2021) (5)
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages (2020) (5)
Effect of repeat prostate biopsies on functional outcomes after radical prostatectomy. (2017) (5)
Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates. (2019) (5)
Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume Center (2016) (5)
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features (2021) (5)
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study. (2019) (5)
Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. (2019) (5)
New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein (2022) (5)
Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response (2021) (5)
Prostate‐specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer‐specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer (2021) (4)
The current role of precision surgery in oligometastatic prostate cancer (2022) (4)
Possible Role of Circulating Tumour Cells for Prediction of Salvage Lymph Node Dissection Outcome in Patients with Early Prostate Cancer Recurrence (2021) (4)
Assessment of the optimal number of positive biopsy cores to discriminate between cancer‐specific mortality in high‐risk versus very high‐risk prostate cancer patients (2021) (4)
[Radical prostatectomy in locally advanced prostate cancer]. (2017) (4)
[Diagnosis of urothelial carcinoma]. (2008) (4)
The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical Prostatectomy (2017) (4)
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021 (2022) (4)
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation (2014) (4)
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (2020) (4)
Improvement in overall and cancer‐specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients (2021) (4)
Is 68Ga-Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography Ready To Simplify the Conundrum of Biochemically Recurrent Prostate Cancer? (2018) (4)
Burden of lymph node metastases in patients with prostate cancer treated with radical prostatectomy and lymph node dissection (2018) (4)
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients (2021) (4)
Long‐term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life‐table data (2021) (4)
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo (2021) (4)
External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy (2019) (4)
Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis (2018) (4)
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltration. (2021) (4)
The effect of primary urological cancers on survival in men with secondary prostate cancer (2021) (4)
Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients (2020) (4)
Circulating Vitamin D and Selenium Levels and Outcome in Prostate Cancer Patients: Lessons from the MARTINI-Lifestyle Cohort. (2021) (4)
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence (2021) (4)
Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study. (2020) (4)
[Diagnostic procedure for bladder cancer. Standards and current developments]. (2010) (4)
Radical prostatectomy improves survival in selected metastatic prostate cancer patients: A North American population‐based study (2021) (4)
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center (2021) (4)
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies. (2019) (4)
Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death (2022) (4)
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions. (2017) (4)
1907 LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM (2013) (4)
[Urine-based markers of angiogenesis in bladder cancer]. (2009) (4)
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. (2021) (4)
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study. (2019) (3)
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder. (2021) (3)
Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort. (2021) (3)
Non‐organ confined stage and upgrading rates in exclusive PSA high‐risk prostate cancer patients (2022) (3)
Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment. (2020) (3)
Radical Prostatectomy: Sequelae in the Course of Time (2021) (3)
Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer (2021) (3)
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy. (2020) (3)
A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer (2021) (3)
Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy (2021) (3)
Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer (2020) (3)
Bladder Cancer Validation of the Diagnostic Value of NMP 22 W BladderChek W Test as a Marker for Bladder Cancer by Photodynamic Diagnosis (2006) (3)
The Decipher Genomic Classifier Independently Improves Prognostication for Patients After Prostatectomy. (2018) (3)
Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies? (2020) (3)
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes. (2019) (3)
Immuno-oncology therapy in metastatic bladder cancer: a systematic review and network meta-analysis. (2021) (3)
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer (2020) (3)
Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy (2021) (3)
Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy. Results from a large prospective randomized trial (2017) (3)
PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy. (2021) (3)
Prostate cancer prognosis in men with other malignancies prior to radical prostatectomy. (2019) (3)
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer (2020) (3)
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate. (2020) (3)
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma (2010) (3)
How can we expand active surveillance criteria in patients with low- and intermediate risk prostate cancer without increasing the risk of misclassification: Development of a novel risk calculator (2018) (3)
Minimizing complications during retropubic radical prostatectomy - is ureteral stenting necessary? (2010) (3)
Transrectal High-Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Current Role * (2013) (3)
The impact of anxiety and depression on surgical and functional outcomes in patients who underwent radical prostatectomy (2018) (3)
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma. (2021) (3)
Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomy. (2020) (3)
MP57-11 DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS (2014) (2)
Comparison of partial vs. radical nephrectomy effect on other cause mortality, cancer specific mortality and 30-day mortality in patients older than 75 years (2018) (2)
Genomic classifiers in personalized prostate cancer radiotherapy approaches - a systematic review and future perspectives based on international consensus. (2022) (2)
The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer. (2021) (2)
Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients (2022) (2)
Epithelial versus endothelial CEACAM1 expression and angiogenesis in epididymal adenomatoid tumor. (2010) (2)
[Organ-sparing surgery for penile cancer]. (2008) (2)
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. (2015) (2)
[Current controversies in the treatment of localized prostate cancer]. (2019) (2)
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups (2022) (2)
In-vitro comparison of laser-induced lithotripsy on artificial stones by means of different laser systems (2008) (2)
Impact of preoperative risk on metastatic progression and cancer specific death in patients with adverse pathology at radical prostatectomy (2017) (2)
Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology (2018) (2)
Survival benefit of local vs. no local treatment for metastatic prostate cancer - impact of baseline PSA and metastatic substages (2018) (2)
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy. (2019) (2)
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical Prostatectomy (2022) (2)
Getting the Balance Right-The Benefits and Uncertainties of Focal Therapy for Significant Prostate Cancer. (2018) (2)
553 DETECTION OF INGUINAL LYMPH NODE INVOLVEM IN PENILE SQUAMOUS CELL CARCINOMA BY 18F-FLUORODEOXYGLUCOSE PET/CT (2010) (2)
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time? (2021) (2)
Oncologic outcomes of organ-confined Gleason grade group 4-5 prostate cancer after radical prostatectomy. (2021) (2)
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients. (2022) (2)
Early prostate cancer recurrence with prostate‐specific membrane antigen positron emission tomography positive unilateral pelvic lesion(s): is one‐sided salvage extended lymph node dissection enough? (ProSTone, NCT04271579) (2021) (2)
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy. (2022) (2)
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. (2021) (2)
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy. (2022) (2)
Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). (2012) (2)
Effect of bladder neck sparing at robot-assisted laparoscopic prostatectomy on postoperative continence rates and biochemical recurrence (2019) (2)
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients (2021) (2)
[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]. (2010) (2)
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma (2021) (2)
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns+ (2021) (2)
Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates (2016) (2)
Prognostic Significance of the Risk of Non-localized Disease on PSMA/PET: Comparative Performance of a Novel, PSMA/PET-Derived Risk Stratification Tool for High-Risk Prostate Cancer in a Large, Multi-Institutional Cohort. (2021) (2)
External Beam Radiotherapy With or Without Brachytherapy Boost in Men with Very High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. (2022) (1)
PIONEER: European Commission Innovative Medicines Initiative funded BD4BO (Big data for better outcome) project on prostate cancer (2020) (1)
923 CLINICAL AND PATHOLOGICAL NODAL STAGING SCORE FOR UROTHELIAL CARCINOMA OF THE BLADDER ARE VALID DECISION TOOLS FOR RISK ASSESSMENT AND CLINICAL DECISION-MAKING: AN EXTERNAL VALIDATION (2013) (1)
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary update. (2018) (1)
Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. (2019) (1)
[Molecular imaging of tumor blood vessels]. (2007) (1)
Effect of bladder neck sparing at robot-assisted laparoscopic prostatectomy on postoperative continence rates and biochemical recurrence. (2019) (1)
Validation of the updated eighth edition of AJCC for prostate cancer: Removal of pT2 substages - Does extent of tumor involvement matter? (2020) (1)
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. (2023) (1)
[Quality criteria in urology : How to obtain comparable results?] (2021) (1)
[Diagnostic work-up for lymph node metastases of urological tumors]. (2010) (1)
Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables (2022) (1)
PD29-04 COMPLICATIONS AND FUNCTIONAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY: A COMPARISON BETWEEN OPEN AND ROBOT-ASSISTED APPROACHES IN A MULTICENTRE SERIES. (2018) (1)
Multiparametric MRI: an important tool to improve risk stratification for active surveillance in prostate cancer (2018) (1)
Advancing age and the risk of adverse pathology at radical prostatectomy in men with biopsy Gleason score 6 prostate cancer. (2020) (1)
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time. (2022) (1)
Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer (2019) (1)
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer (2022) (1)
LYMPHANGIOGENESIS IN PROSTATE CANCER: NEW INSIGHTS INTO MOLECULAR MECHANISMS (2008) (1)
1596 GENDER-SPECIFIC DIFFERENCES IN CARCINOMA-SPECIFIC SURVIVAL AFTER RADICAL CYSTECTOMY FOR PATIENTS WITH UROTHELIAL CARCINOMA OF THE URINARY BLADDER IN PATHOLOGICAL TUMOUR STAGE T4A (2012) (1)
Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity. (2022) (1)
Is it worth to perform radical prostatectomy in a salvage setting? Results of a contemporary multicentre series of 395 cases (2018) (1)
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi (2023) (1)
Contemporary trends and survival outcomes after aborted radical prostatectomy in lymph node metastatic prostate cancer patients (2018) (1)
Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer (2020) (1)
PD07-06 COMPARISON OF PARTIAL VS. RADICAL NEPHRECTOMY EFFECT ON OTHER CAUSE MORTALITY, CANCER SPECIFIC MORTALITY AND 30-DAY MORTALITY IN PATIENTS OLDER THAN 75 YEARS (2018) (1)
MRI as a screening tool for prostate cancer: current evidence and future challenges (2022) (1)
127 OPTICAL COHERENCE TOMOGRAPHY (OCT) - A MINIMALLY INVASIVE TECHNIQUE FOR THE DETECTION OF BLADDER LESIONS (2009) (1)
MP82-05 A COMPARISON OF DIFFERENT TREATMENT OPTIONS FOR LYMPH NODE-POSITIVE PROSTATE CANCER AT RADICAL PROSTATECTOMY (2015) (1)
Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan‐confined prostate cancer (2022) (1)
Prostate cancer: Comparing quality of life outcomes after prostate cancer treatment (2017) (1)
Toxicity in a multimodality approach of radical prostatectomy with radiation and hormonal therapy. (2016) (1)
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy (2022) (1)
Effect of extended pelvic lymph node dissection on oncologic outcomes in D’Amico intermediate- and high-risk radical prostatectomy patients (2018) (1)
Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs? (2023) (1)
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. (2022) (1)
Complications after salvage radical prostatectomy: vesicourethral anastomosis leaks and possible prevention (2017) (1)
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series. (2022) (1)
Hormonal Treatment for Nonmetastatic Disease Recurrence After Curative Treatment of Prostate Cancer: Only for a Select Few. (2016) (1)
1830 IMPACT OF HISTOLOGIC SUBTYPE ON TUMOR THROMBUS LEVEL AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS (2013) (1)
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer (2022) (1)
PI-07 A TRANSPLANT-BASED SURGICAL APPROACH MAY IMPROVE POSTOPERATIVE COMPLICATIONS IN CASES OF RENAL CELL CARCINOMA AND TUMOR THROMBUS (2015) (1)
Questioning the status quo: Should Gleason Grade Group 1 prostate cancer be considered a "negative core" in pre-radical prostatectomy risk nomograms? An international multicenter analysis. (2019) (1)
Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram (2018) (1)
247 PT3 SUBSTAGING IS A PROGNOSTIC INDICATOR IN LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER (2011) (1)
Trend of use of adjuvant and salvage radiation therapy after radical prostatectomy and impact on long-term outcomes: Results from three high volume centers over the last two decades (2018) (1)
Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer (2021) (1)
Accuracy of 68Ga-PSMA-PET for the detection of lymph node metastases before salvage lymphadenectomy – a real life scenario (2018) (1)
The EAU biochemical recurrence risk stratification after radical prostatectomy (2020) (1)
Metastases-yield and PSA-kinetics following salvage lymph node dissection: A comparison between conventional surgical approach and radio-guided surgery (2018) (1)
MP11-05 ONCOLOGICAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY IN A CONTEMPORARY, MULTICENTRE SERIES OF 395 CASES (2018) (1)
MP30-13 IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS (2014) (1)
Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates (2022) (1)
Salvage chemotherapy with cisplatin, ifosfamide, and paclitaxel in metastatic castration-resistant prostate cancer. (2021) (1)
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort. (2023) (1)
MP83-16 HETEROGENEITY IN D'AMICO LOW-RISK PROSTATE CANCER: DIFFERENCES IN UPGRADING AND UPSTAGING ACCORDING TO ACTIVE SURVEILLANCE ELIGIBILITY (2015) (1)
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer (2022) (1)
OPTICAL COHERENCE TOMOGRAPHY (OCT) - A MINIMALLY INVASIVE TECHNIQUE FOR THE DETECTION OF LESIONS WITHIN THE BLADDER (2009) (1)
Functional outcomes and complications of a multicentre series of open versus robot-assisted salvage radical prostatectomy (2017) (1)
33 VALIDATION OF THE AJCC TNM SUBSTAGING OF PT2 BLADDER CANCER: DEEP MUSCLE INVASION IS ASSOCIATED WITH SIGNIFICANTLY WORSE OUTCOME (2010) (1)
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival. (2022) (1)
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study (2021) (1)
Assessing the 20-year outcomes of lymph node positive prostate cancer patients: A plea for lifelong follow-up (2018) (1)
MP43-08 INCREASING RATES OF NCCN HIGH AND VERY HIGH-RISK PROSTATE CANCER VS. NUMBER OF PROSTATE BIOPSY CORES (2021) (1)
THE IMPACT OF ANXIETY AND DEPRESSION ON FUNCTIONAL OUTCOME IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY: PD51‐04 (2017) (1)
PD45-11 IDENTIFYING THE OPTIMAL DEFINITION FOR EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: A RISK-STRATIFIED APPROACH TO OPTIMIZE POSTOPERATIVE FOLLOW-UP AND THE USE OF TIMELY SALVAGE THERAPIES (2019) (1)
Analysis of small non-coding RNAs in urinary exosomes to classify prostate cancer into low-grade (GG1) and higher-grade (GG2-5). (2020) (1)
Regression Discontinuity Analysis of Salvage Radiotherapy in Prostate Cancer. (2019) (1)
MP44-17 THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC) (2015) (1)
PSA persistence after radical prostatectomy and its impact on oncologic outcomes (2019) (1)
199 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CLINICAL CARCINOMA IN SITU ONLY TREATED WITH RADICAL CYSTECTOMY: AN INTERNATIONAL STUDY OF 243 PATIENTS (2010) (1)
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy (2017) (1)
MP78-09 5-YEARS BIOCHEMICAL RECURRENCE AND OVERALL SURVIVAL RATES AFTER RADICAL PROSTATECTOMY OR HIGH DOSE RADIATION BRACHYTHERAPY WITH ADDITIONAL EXTERNAL BEAM IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER (2015) (1)
521 Impact of surgical volume on perioperative outcomes after nephrectomy with tumor thrombectomy (2016) (1)
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core. (2022) (1)
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study (2018) (0)
970: Dual Role of CEACAM1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer (2004) (0)
537 CONTEMPORARY OUTCOMES OF RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER (2009) (0)
B2B: Prostate Cancer (2021) (0)
35 CONCOMITANT CARCINOMA IN SITU IS NOT ASSOCIATED WITH CLINICAL OUTCOMES AFTER RADICAL CYSTECTOMY (2010) (0)
Oncological and functional outcomes after RP for high or very high-risk prostate cancer – European validation of the current NCCN guideline (2017) (0)
Risk Assessment Based on Molecular and Genetic Markers in Prostate Cancer (2019) (0)
MP60-02 FUNCTIONAL OUTCOMES AND COMPLICATIONS OF SALVAGE RADICAL PROSTATECTOMY FOR RECURRENT PROSTATE CANCER: A LARGE, RECENT MULTICENTER SERIES (2019) (0)
602 The extent of lymphadenectomy in radical cystectomy for bladder cancer influences disease-free survival (2012) (0)
Chapter 15 Interventional treatment: transurethral resection of the prostate (TURP) (2011) (0)
Race/ethnicity is an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients (2021) (0)
Performance characteristics of PET/CT scan in men treated with salvage lymph node dissection for recurrent prostate cancer: a per patient analysis with pathological confirmation according to each area of dissection (2020) (0)
Abstract 1298: Mechanisms of endothelial trophic support of genitourinary tumors (2010) (0)
African American vs. Caucasian race/ethnicity in adrenocortical carcinoma patients. (2023) (0)
[Imaging diagnostics of advanced prostate cancer]. (2013) (0)
MP57-12 CANCER-SPECIFIC SURVIVAL AND PREDICTORS IN PATIENTS WITH CT3B KIDNEY CANCER: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM (2014) (0)
MP53-04 RATES OF UPGRADING AND UPSTAGING IN PROSTATE CANCER PATIENTS WITH SINGLE GGG1 POSITIVE BIOPSY CORE (2022) (0)
MP3-16 DETAILED ASSESSMENT OF LOWER URINARY TRACT SYMPTOMS AND ERECTILE FUNCTION AFTER HOLEP: A PROSPECTIVE STUDY (2015) (0)
Editorial Comment. (2017) (0)
243 PREDICTION OF LOCALLY ADVANCED BLADDER CANCER BEFORE CYSTECTOMY AND OUTCOME ASSESSMENT OF PATIENTS WITH BLADDER CANCER AFTER CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS (2011) (0)
External validation of Stockholm3 in a retrospective German clinical cohort (2023) (0)
IMPACT OF PERITONEAL BLADDER FLAP ON THE RISK OF SYMPTOMATIC LYMPHOCELES AFTER ROBOTIC RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMISED-CONTROLLED TRIAL (2023) (0)
PD-0671: Matched pair analysis of salvage radiotherapy vs observation for post-prostatectomy PSA recurrence (2020) (0)
PD29-11 IMPACT OF BILATERAL NEUROVASCULAR BUNDLE PRESERVATION ON ONCOLOGICAL OUTCOMES IN NON-ORGAN CONFINED PROSTATE CANCER (2018) (0)
Localized Prostate Cancer: Exploring the Boundaries of Current Treatment Paradigms. (2020) (0)
EAU BCR risk classification as decision tool for salvage radiotherapy? A multicenter study (2021) (0)
PD08-03 EAU BCR RISK CLASSIFICATION AS DECISION TOOL FOR SALVAGE RADIOTHERAPY? A MULTICENTER STUDY (2021) (0)
Current treatment options for locally advanced prostate cancer: EAU (-SIOG) guidelines view and recommendations (2020) (0)
FUNCTIONAL OUTCOME OF RADICAL PROSTATECTOMY AFTER REPEAT BIOPSY: MP97‐14 (2017) (0)
MP54-19 REFINING PATIENT SELECTION FOR SALVAGE RADICAL PROSTATECTOMY: EAU GUIDELINES-COMPLIANT PATIENTS SHOW BETTER OUTCOMES (2019) (0)
The AJCC 8th edition no longer substages pT2 prostate cancer: Does extent of tumor involvement not matter? (2019) (0)
Regional differences in total hospital costs for radical cystectomy in the United States. (2023) (0)
Feasibility, acceptability, and behavioral outcomes of a multimodal intervention for prostate cancer patients: Experience from the MARTINI lifestyle program. (2023) (0)
MP67-18 IMPACT OF PERSISTENT PSA IN SALVAGE RADICAL PROSTATECTOMY PATIENTS - A MULTICENTER STUDY (2023) (0)
MP64-13 IMPACT OF SURGICAL VOLUME ON PERIOPERATIVE OUTCOMES AFTER NEPHRECTOMY WITH TUMOR THROMBECTOMY (2016) (0)
1825 CLINICAL OUTCOME IN PATIENTS WITH PT4 UROTHELIAL CARCINOMA AT RADICAL CYSTECTOMY (2010) (0)
Identifying the optimal candidates for radiation therapy after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Results from a multi-institutional collaboration (2021) (0)
PROSTATECTOMY ON BIOCHEMICAL RECURRENCE RATES (2015) (0)
Is focal therapy for prostate cancer an attractive option? Results of an international survey from the young academic urologists (YAU) amongst 484 physicians (2018) (0)
Increased risk of postoperative in‐hospital complications after radical prostatectomy in patients with prior organ transplant (2021) (0)
MP11-20 OTHER MALIGNANCIES PRIOR PROSTATE CANCER DIAGNOSIS – CLINICAL OUTCOME AFTER RADICAL PROSTATECTOMY (2018) (0)
PCN97 Budget IMPACT of Oncotype DX GPS ASSAY in Patients with Localized Prostate Cancer in Germany (2020) (0)
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives (2021) (0)
MP79-01 EXTERNAL VALIDATION OF THE 2019 BRIGANTI NOMOGRAM FOR THE IDENTIFICATION OF PROSTATE CANCER PATIENTS WHO SHOULD BE CONSIDERED FOR AN EXTENDED PELVIC LYMPH NODE DISSECTION (2020) (0)
Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy (2023) (0)
286 Clinical and pathological nodal staging score for urothelial carcinoma of the bladder are valid decision tools for risk assessment and clinical decision-making: An external validation (2013) (0)
775 Female gender is associated with worse cancer-specific survival after radical cystectomy for urothelial bladder carcinoma: Multicenter analysis of 2,483 patients (2012) (0)
Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer. (2023) (0)
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. (2023) (0)
172 RNA interference-mediated knock-down of CHD1 in human prostate xenograft tumours alters tumour growth and metastatic behaviour (2015) (0)
FUNCTIONAL OUTCOMES AND QUALITY OF LIFE AFTER RADICAL PROSTATECTOMY: PATIENT REPORTED OUTCOMES OF A TERTIARY HIGH‐VOLUME CENTER: PD10‐04 (2017) (0)
36 OUTCOME PREDICTION IN PATIENTS WITH BLADDER CANCER AFTER CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS (2010) (0)
ARE THE RESULTS OF THE PROTECT TRIAL APPLICABLE TO CONTEMPORARY PROSTATE CANCER PATIENTS TREATED AT TWO HIGH‐VOLUME EUROPEAN INSTITUTIONS?: PD51‐01 (2017) (0)
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy (2023) (0)
Which patients with low-risk prostate cancer are still receiving radical prostatectomy? Impact of patient selection on inverse stage migration at two european, tertiary referral centers (2018) (0)
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients (2022) (0)
Reply by Authors. (2020) (0)
Prostate cancer in renal transplant recipients: Results from a large multicentre contemporary cohort (2021) (0)
Stage-migration and survival of lymph node positive prostate cancer patients: A comprehensive trend analyses of surgically treated men over the last two decades (2018) (0)
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities (2023) (0)
Prognostic impact of different Gleason patterns within grade group 4 prostate cancer in radical prostatectomy specimens (2021) (0)
866 ASSOCIATION BETWEEN THE EXTENT OF PELVIC LYMPHADENECTOMY AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER UNDERGOING RADICAL CYSTECTOMY (2011) (0)
MP53-02 SALVAGE RADIOTHERAPY VERSUS OBSERVATION FOR BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A MATCHED PAIR ANALYSIS (2020) (0)
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity (2022) (0)
1764 COMPARATIVE ONCOLOGIC EFFECTIVENESS BETWEEN ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY (2013) (0)
Medicines and methods for the treatment of prostate cancer (2007) (0)
556 SURGEON'S LEARNING CURVE FOR OPEN RADICAL PROSTATECTOMY (2013) (0)
524 Preoperative renal artery embolization in renal carcinoma with venous thrombus: Preliminary results of a multicenter study (2016) (0)
Oncological and functional outcome after radical prostatectomy in men ≤45 years of age (2017) (0)
MP22-12 ONCOLOGICAL OUTCOMES IN PATIENTS WITH HIGH LYMPH NODE BURDEN AFTER RADICAL PROSTATECTOMY (2019) (0)
845 CEACAM1 DISTRIBUTION AND ITS ROLE IN LYMPH NODE METASTASIS IN PENILE CANCER (2010) (0)
VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS UNDERGOING OPEN AND MINIMALLY INVASIVE RADICAL PROSTATECTOMY: POPULATION‐BASED TIME TREND ANALYSIS: MP97‐09 (2017) (0)
Re: Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. (2016) (0)
MP60-07 EFFECT OF BLADDER NECK SPARING AT ROBOT-ASSISTED LAPAROSCOPIC PROSTATECTOMY ON POSTOPERATIVE CONTINENCE RATES AND BIOCHEMICAL RECURRENCE (2019) (0)
MP83-05 THE EFFECT OF NERVE-SPARING ON URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY: IS IT THE PRESERVATION OF THE NEUROVASCULAR BUNDLES OR THE SURGICAL TECHNIQUE WHICH LEADS TO IMPROVED CONTINENCE RATES? (2015) (0)
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo (2021) (0)
Acute Urinary Retention (2014) (0)
Epidemiology of Unconventional Histological Subtypes of Urethral Cancer (2022) (0)
Assessing the association between the template of pelvic salvage lymph node dissection for node-only recurrent prostate cancer and oncological outcomes. Results of a multi-institutional series (2021) (0)
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level (2022) (0)
Impact of additional radiation and/or androgen deprivation therapy on functional outcomes after radical prostatectomy (2017) (0)
184 VALUE OF 18F-CHOLINE PET/CT IN DETECTION OF LYMPH-NODE METASTASES IN PATIENTS WITH PSA FAILURE AFTER RADICAL PROSTATECTOMY: HISTOLOGICAL VERIFICATION AFTER SECONDARY LYMPHADENECTOMY (2012) (0)
What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series (2020) (0)
PD34-05 IMPACT OF PREVIOUS WHOLE PELVIS RADIATION THERAPY IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER NODE-ONLY RECURRENCE: EVALUATION OF SURGICAL, PATHOLOGICAL, AND ONCOLOGICAL OUTCOMES (2021) (0)
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients. (2023) (0)
Nerve-Sparing Radical Prostatectomy (NSRP) using the NeuroSAFE technique is oncologically safe: Results after 20 years of experience (2023) (0)
MP38-15 EXTRACAPSULAR EXTENSION AND LYMPH NODE DENSITY IN UROTHELIAL CARCINOMA OF THE BLADDER FOLLOWING RADICAL CYSTECTOMY IN NODAL-POSITIVE PATIENTS (2016) (0)
Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages (2023) (0)
MP34-11 METASTASES-YIELD AND PSA-KINETICS FOLLOWING SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER: A COMPARISON BETWEEN CONVENTIONAL SURGICAL APPROACH AND PSMA-RADIOGUIDED SURGERY (2019) (0)
445 Time to catheter removal after radical prostatectomy has no adverse effect on intermediate-and long-term continence rates (2016) (0)
603 Clinical nodal staging scores for bladder cancer: A proposal for preoperative risk-assessment (2012) (0)
Stage-migration and survival of lymph node positive prostate cancer patients: A comprhensive trend analyses of surgically treated men over the last two decades (2018) (0)
Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with non-organ-confined prostate cancer (2020) (0)
Re: Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer. (2021) (0)
Utility of urine biomarkers (2015) (0)
MP83-15 THE IMPACT OF NOT DETERMINABLE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY (2015) (0)
Diagnostic Performance of 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results. (2023) (0)
MP22-03 LONG-TERM ONCOLOGIC OUTCOMES OF PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2019) (0)
Metastases-yield and PSA-kinetics following salvage lymph node dissection for prostate cancer: A comparison between conventional surgical approach and PSMA-radioguided surgery (2019) (0)
635 External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort (2015) (0)
907 Lymph node–positive prostate cancer at radical prostatectomy: What is the optimal treatment? (2015) (0)
Impact of Intraoperative Frozen Section (NeuroSAFE) during robotic radical prostatectomy on rates of nerve-sparing and positive margins in patients with preoperative mpMRI and PSMA PET/CT: Initial experience (2021) (0)
1982 NODAL YIELD IS NOT INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY (2011) (0)
The impact of high initial PSA (≥50 ng/ml) at the time of radical prostatectomy for clinically localized prostate cancer on cancer specific survival (2019) (0)
MP11-17 RADICAL PROSTATECTOMY AFTER PREVIOUS TUR-P: ONCOLOGICAL, SURGICAL AND FUNCTIONAL OUTCOMES (2018) (0)
Validation of a two-gene mRNA urine test for detection of high-grade prostate cancer in German men. (2019) (0)
323 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN RADICAL CYSTECTOMY PATIENTS (2010) (0)
1753 EXTENT OF LYMPHADENECTOMY IN RADICAL CYSTECTOMY FOR BLADDER CANCER INFLUENCES DISEASE-FREE SURVIVAL – A PROSPECTIVE SINGLE-CENTER STUDY (2012) (0)
PD16-04 DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER (2023) (0)
Prox1 CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Lymphatic reprogramming of microvascular endothelial cells by (2010) (0)
Development and external validation of a novel risk score to predict long-term clinical recurrence after radical prostatectomy (2019) (0)
Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities (2021) (0)
Machine Learning for the Prediction of Lymph Node Metastasis in Patients with Prostate Cancer (2022) (0)
Validation of EAU recommendation for salvage radical prostatectomy candidates (2021) (0)
Impact of peritoneal bladder flap on the risk of lymphoceles after robotic radical prostatectomy: Results of a prospective controlled trial (2023) (0)
MP50-06 SURVIVAL OF TESTICULAR PURE TERATOMA VS. MIXED GERM CELL TUMOR PATIENTS ACROSS ALL STAGES (2023) (0)
Obesity was associated with improved metastases-free survival after surgery in 13,667 prostate cancer patients (2017) (0)
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter study (2020) (0)
ALTERATION OF METASTATIC BEHAVIOR BY SHRNA MEDIATED KNOCKDOWN (KD) OF CHD1 IN HUMAN PROSTATE XENOGRAFT TUMORS AND CLINICAL OUTCOME OF PATIENTS WITH CHD1 DELETION: MP28‐03 (2017) (0)
MP11-07 RADIOLIGAND THERAPY WITH 177Lu-PSMA-I&T IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: ONCOLOGICAL OUTCOMES AND TOXICITY PROFILE (2023) (0)
Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection. (2022) (0)
PD29-08 IMPACT OF BLOOD LOSS DURING RADICAL PROSTATECTOMY ON FUNCTIONAL OUTCOMES (2018) (0)
Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation management (2022) (0)
Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort (2022) (0)
PERIOPERATIVE COMPLICATIONS OF RADICAL CYSTECTOMY IN THE ELDERLY PATIENT (2009) (0)
MP11-16 POSTOPERATIVE COMPLICATIONS OF CONTEMPORARY OPEN AND ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY USING STANDARDIZED REPORTING SYSTEMS (2018) (0)
591 PT1 G2 PENILE CARCINOMA – A TUMOR WITH HIGH METASTATIC POTENTIAL (2011) (0)
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer. (2023) (0)
MORE EXTENSIVE LYMPHADENECTOMY IMPROVES OUTCOMES OF RADICAL CYSTECTOMY FOR BLADDER CANCER IN A NATIONWIDE MULTICENTER EVALUATION (2009) (0)
Preprostatic lymph nodes in prostate cancer hot or not? Impact on oncological outcome after radical prostatectomy (2022) (0)
Management of Localized and Locally Advanced Prostate Cancer (2020) (0)
Robot-assisted versus open radical prostatectomy: Outcomes of highly experienced surgeons for both approaches (2023) (0)
PD45-12 DEVELOPMENT AND EXTERNAL VALIDATION OF A NOVEL RISK SCORE TO PREDICT LONG-TERM CLINICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2019) (0)
Patient selection is key for salvage surgery in prostate cancer: EAU guidelines-compliant and non-compliant patients show different outcomes (2020) (0)
MORBIDITY AND FUNCTIONAL OUTCOMES OF OPEN AND ROBOTIC SALVAGE RADICAL PROSTATECTOMY: DATA FROM A LARGE, RECENT, MULTICENTER SERIES (2019) (0)
TUMOR ANGIOGENESIS REGULATION IN PROSTATE CANCER BY CEACAM1 (2008) (0)
PD10-03 PROGNOSTIC IMPACT OF LYMPH VESSEL INVASION IN RADICAL PROSTATECTOMY PATIENTS (2023) (0)
Impact of persistent PSA in salvage radical prostatectomy patients for recurrent prostate cancer (2022) (0)
Is there an impact of transperineal vs. transrectal MRI-targeted biopsy on the risk of upgrading and concordance with final pathology in prostate cancer patients undergoing radical prostatectomy? An EAU-YAU study (2023) (0)
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer (2020) (0)
Choosing the right patient for salvage radical prostatectomy: Oncological outcomes compared between eau guidelines-compliant and non-compliant patients (2019) (0)
NEW MARKERS OF HUMAN URINARY BLADDER CANCER REVEALED BY URINARY PROTEOMICS (2008) (0)
804 Radical prostatectomy in transplant patients (2015) (0)
628 Nerve-sparing surgery technique but not the preservation of the neurovascular bundles leads to improved long-term continence rates after radical prostatectomy (2015) (0)
Diagnostic accuracy of PSMA PET/CT in primary lymph node staging prior to radical prostatectomy (2023) (0)
EAU BCR risk classification as decision tool for salvage radiatiotherapy (2020) (0)
MP22-06 IMAGING TARGETED TREATMENTS VERSUS EXTENDED SALVAGE LYMPH NODE DISSECTION FOR PATIENTS WITH A SINGLE NODAL RECURRENCE OF PROSTATE CANCER: A COMPARATIVE ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2019) (0)
MP80-11 TUMOR CHARACTERISTICS, ONCOLOGICAL AND OVERALL OUTCOME AFTER RADICAL PROSTATECTOMY IN MEN 75 YEARS AND OLDER (2016) (0)
[Influence of modern diagnostic methods on the treatment of nonmetastatic castration-resistant prostate cancer]. (2019) (0)
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. (2023) (0)
Negative PSMA PET/CT can be used to reduce the number of unnecessary PLND in intermediate risk prostate cancer (2023) (0)
Risk of metastasis in patients with delayed biochemical recurrence 10 years after radical prostatectomy (2020) (0)
DOES THE TRAINING LEVEL OF THE FIRST ASSISTANT HAS AN IMPACT ON BLOOD LOSS IN RADICAL PROSTATECTOMIES (2008) (0)
Reply by Authors. (2019) (0)
Abstract 327: Targeting autophagy overcomes enzalutamide resistance in castrate-resistant prostate cancer cells and improves therapeutic response in a xenograft model (2014) (0)
MP53-12 EAU BCR RISK CLASSIFICATION AS DECISION TOOL FOR SALVAGE RADIOTHERAPY (2020) (0)
Editorial Comment. (2020) (0)
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages (2023) (0)
Impact of blood loss during radical prostatectomy on the functional outcome (2018) (0)
Reply to the letter to the editor: RE: Preisser F, et al. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. The Prostate. 2018;1‐7 (2018) (0)
POPULATION‐BASED VALIDATION OF THE 2014 ISUP GLEASON GRADING GROUPING IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY, BRACHYTHERAPY, EXTERNAL BEAM RADIATION OR NO LOCAL TREATMENT: MP20‐03 (2017) (0)
322 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PT4 UROTHELIAL CARCINOMA AT RADICAL CYSTECTOMY: A RETROSPECTIVE INTERNATIONAL STUDY OF 583 PATIENTS (2010) (0)
Functional outcomes and complications of open versus robot-assisted salvage radical prostatectomy: Results of a multicentre study (2018) (0)
Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Clinical Implications for multi-modal therapy (2021) (0)
872 External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder (2012) (0)
1830 CHARACTERIZATION AND RISK STRATIFICATION OF PROSTATIC MALIGNANCY IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY (2010) (0)
ASSESSMENT OF ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY ACCORDING TO PREOPERATIVE AND POSTOPERATIVE CAPRA RISK SCORES: RESULTS OF A LARGE, TWO‐CENTER EXPERIENCE.: MP47‐14 (2017) (0)
523 Impact of lymph node dissection at the time of radical nephrectomy and tumour thrombectomy on oncological outcomes of patients with renal cell carcinoma and tumour thrombus (2016) (0)
Gleason grade grouping: The significance of primary Gleason 5 in patients with Gleason grade group 5 (2019) (0)
MP75-14 ANALYSIS OF SMALL NON-CODING RNAS IN URINARY EXOSOMES ACCURATELY CLASSIFIES PROSTATE CANCER INTO LOW GRADE AND HIGHER GRADE DISEASE (2020) (0)
MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL (2022) (0)
REGULATION OF LYMPHANGIOGENESIS IN PROSTATE CANCER (2008) (0)
1400 CLINICAL NODAL STAGING SCORES FOR BLADDER CANCER A NEW PREOPERATIVELY NODAL ASSESSMENT TOOL (2012) (0)
Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies (2021) (0)
MP60-13 PERIOPERATIVE MANAGEMENT OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY; RESULTS OF A PROSPECTIVE ASSESSMENT (2019) (0)
1010 Value of 18F-Choline PET/CT in detection of lymph-node metastases in patients with PSA failure after radical prostatectomy: Histological verification after secondary lymphadenectomy (2012) (0)
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer (2022) (0)
PD37-10 LONG-TERM ONCOLOGICAL OUTCOMES IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2016) (0)
Oncologic long-term outcome in patients with pathologic Gleason 3+3 score at radical prostatectomy (2017) (0)
MP64-05 A NEW MODEL FOR PREDICTION OF HIGH-RISK FEATURES AMONG UNFAVORABLE INTERMEDIATE RISK PROSTATE CANCER PATIENTS (2021) (0)
Reply to Benefit‐harm ratio of the diagnostic workup in patients with prostate cancer of Gleason score from 9 to 10 (2021) (0)
MP80-17 LONG-TERM ONCOLOGICAL OUTCOMES IN PATIENTS WITH PATHOLOGIC GLEASON 3+3 SCORE AT RADICAL PROSTATECTOMY (2016) (0)
[Multimodal treatment of high-risk and locally advanced prostate cancer]. (2022) (0)
Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11] (2022) (0)
EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS: PD04‐10 (2017) (0)
Halving the risk of symptomatic lymphoceles after radical prostatectomy: Results of a randomised-controlled study including 1080 patients (2020) (0)
MP83-07 SALVAGE RADICAL PROSTATECTOMY FOR RECURRENT PROSTATE CANCER: VERIFICATION OF EAU GUIDELINE CRITERIA (2015) (0)
Contemporary conditional cancer-specific survival rates in stage III non-seminoma testis cancer patients: A population-based analysis (2023) (0)
Radiation therapy after radical prostatectomy is associated with higher other-cause mortality (2021) (0)
1032 VALIDATION OF RESIDUAL PATHOLOGIC STAGE AT RADICAL CYSTECTOMY AS A PROGNOSTIC FACTOR IN PATIENTS WITH CT2N0 BLADDER CANCER (2010) (0)
151 NATURAL TREATED HISTORY OF PATIENTS WITH UROTHELIAL CARCINOMA IN SITU (2007) (0)
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma (2023) (0)
MiR Scientific Sentinel Scores - a new platform technology for identification of clinically significant prostate cancer using miRNA and snoRNA expression signatures (2019) (0)
MP74-12 THROMBOEMBOLIC EVENTS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH HEREDITARY THROMBOPHILIA DUE TO FACTOR V LEIDEN (2020) (0)
A systematic review on the impact of surgeon and hospital caseload volume on oncological and non-oncological outcomes after radical prostatectomy for non-metastatic prostate cancer (2021) (0)
Contemporary complications after radical prostatectomy (2017) (0)
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study (2020) (0)
244 MULTICENTRIC VALIDATION OF NOMOGRAMS TO PREDICT LOCALLY ADVANCED UROTHELIAL CANCER OF THE BLADDER AND SURVIVAL RATES FOLLOWING RADICAL CYSTECTOMY (2011) (0)
Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient stratification for tailored post-operative treatments (2020) (0)
Salvage radical prostatectomy after biochemical recurrence of malignancy: A multicentre study of 18 tertiary referral centres (2018) (0)
Prostate biopsies before pre-salvage radical prostatectomy: Do they rightly confirm the final histology? (2018) (0)
CEACAM1 IS A NEW URINARY MARKER FOR BLADDER CANCER (2009) (0)
Morphological and Molecular Characteristics of Tumor Blood Vessels (2009) (0)
MP53-03 PERFORMANCE OF QUANTITATIVE GLEASON GRADING: A HEAD TO HEAD COMPARISON WITH CAPRA SCORE AND D`AMICO GROUPS (2018) (0)
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations (2023) (0)
Long-term validation on the impact of PSMA-PET on metastasis-free survival in a large salvage radiotherapy cohort (2021) (0)
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. (2023) (0)
MP42-11 SALVAGE LYMPH NODE DISSECTION AFTER RADICAL PROSTATECTOMY IN 58 PATIENTS WITH PSA-RECURRENCE AND POSITIVE LYMPH NODES IN PET-CT-SCAN (2014) (0)
MP60-10 IMPACT OF POSITIVE SURGICAL MARGIN LENGTH AND GLEASON GRADE AT THE MARGIN ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH ORGAN-CONFINED PROSTATE CANCER (2019) (0)
OBESITY WAS ASSOCIATED WITH IMPROVED METASTASES‐FREE SURVIVAL AFTER SURGERY IN 13,667 PROSTATE CANCER PATIENTS: MP47‐04 (2017) (0)
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis (2023) (0)
487 LYMPH NODE DENSITY AFFECTS CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH LYMPH NODE-POSITIVE UROTHELIAL BLADDER CANCER FOLLOWING RADICAL CYSTECTOMY (2011) (0)
Machine Learning for the Prediction of Distant Metastases Following Postprostatectomy Salvage Radiation Therapy (2022) (0)
Radical vs. partial cystectomy for urachal carcinoma: A population-based analysis (2022) (0)
MP21-15 WHEN CAN BIOCHEMICAL RECURRENCE BE CONSIDERED A SURROGATE FOR HARDER CLINICAL ENDPOINTS IN HIGH RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL, LONG-TERM ANALYSES (2018) (0)
Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities (2021) (0)
PD40-02 ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER: IMPACT OF VARIOUS DEFINITIONS ON CANCER-SPECIFIC AND OVERALL MORTALITY (2019) (0)
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma. (2022) (0)
Reply by Authors. (2019) (0)
The outcomes of active surveillance of prostate cancer in renal transplant patients: A propensity score matched comparison with a non-renal transplant cohort with prostate cancer (2021) (0)
V11-11 THE MICHL TECHNIQUE TO REDUCE THE INCIDENCE OF SYMPTOMATIC LYMPHOCELES FOLLOWING ROBOT ASSISTED RADICAL PROSTATECTOMY.PATHOPHYSIOLOGY, SURGICAL PROCEDURE, AND EARLY RESULTS OF A RANDOMISED TRIAL (2019) (0)
Nationwide in-hospital morbidity and mortality following radical prostatectomy in Germany (2023) (0)
Lymphadenektomie (2023) (0)
Effect of tumor characteristics on functional outcomes after radical prostatectomy (2020) (0)
[Image-guided punch biopsy of the prostate]. (2012) (0)
1014 Salvage radical prostatectomy for recurrent prostate cancer: Validation of EAU guideline criteria (2015) (0)
970: Laser Induced Shockwave Lithotripsy (LISL): In Vitro Comparison of 5 Different Clinical Laser Systems (2007) (0)
ONCOLOGICAL AND FUNCTIONAL OUTCOMES AFTER RP FOR HIGH OR VERY HIGH‐RISK PROSTATE CANCER – EUROPEAN VALIDATION OF THE CURRENT NCCN GUIDELINE: PD51‐12 (2017) (0)
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death (2023) (0)
817 Dual role of CEACAMI in angiogenesis and invasion of human urinary bladder cancer (2004) (0)
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomy (2022) (0)
Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients (2021) (0)
Review Vascular wall-resident stem cells (2010) (0)
870 CEACAM1 EXPRESSION DISTINGUISHES INDOLENT FROM LETHAL PROSTATE CANCER (2010) (0)
MP69-03 ASSOCIATION BETWEEN LYMPH NODE COUNTS AND ONCOLOGICAL OUTCOMES IN LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS (2016) (0)
Are we improving functional outcomes of prostate cancer patients treated with robot-assisted radical prostatectomy? A 10-year analysis in men treated at two high volume, tertiary referral centers (2019) (0)
82 LASER INDUCED SHOCKWAVE LITHOTRIPSY (LISL): IN VITRO COMPARISON OF 5 DIFFERENT CLINICAL LASER SYSTEMS (2007) (0)
MP66-12 NEOADJUVANT ANDROGEN DEPRIVATION THERAPY PRIOR TO RADICAL PROSTATECTOMY FOR LOCALLY VERY ADVANCED (CT4) PROSTATE CANCER (2019) (0)
[Established and novel options in the surgical treatment of lower urinary tract symptoms]. (2009) (0)
What is learning curve of robot-assisted radical prostatectomy (RARP) in a very highvolume open radical prostatectomy (RRP) center: Experience of a propensity matched-pair analysis of 10719 patients (2018) (0)
Management of Metastatic Castrate-sensitive Prostate Cancer (2018) (0)
MP78-20 OPEN RADICAL PROSTATECTOMY IN TRANSPLANT PATIENTS. (2015) (0)
MP73-02 FOCAL THERAPY - 7 YEARS EXPERIENCE WITH FOCAL HIGH INTENSITY FOCUSED ULTRASOUND IN 164 PATIENTS WITH PROSTATE CANCER: SINGLE CENTER RESULTS (2023) (0)
ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer? (2021) (0)
Early urinary continence a reliable marker for further functional outcomes (2020) (0)
Reply by Authors. (2021) (0)
MP22-01 TREND OF USE OF ADJUVANT AND SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY AND IMPACT ON LONG-TERM OUTCOMES: RESULTS FROM THREE HIGH VOLUME CENTERS OVER THE LAST TWO DECADES (2018) (0)
Update zur adjuvanten vs. Early-Salvage-Radiotherapie nach radikaler Prostatektomie (2021) (0)
PD43-04 SALVAGE RADICAL PROSTATECTOMY FOR RECURRENT PROSTATE CANCER: ONCOLOGICAL OUTCOMES OF A CONTEMPORARY MULTICENTER STUDY (2020) (0)
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma (2021) (0)
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost: Comparison of outcomes in a multi-institutional analysis of patients with high-risk prostate cancer (2020) (0)
Evaluation of Risk Factors for Adverse Functional Outcomes after Radical Prostatectomy in Patients with Previous Transurethral Surgery of the Prostate (2021) (0)
PD63-03 TREATMENT INTENSIFICATION AND OUTCOME IN HIGH-RISK PROSTATE CANCER (2020) (0)
Validation and survival of biopsy Gleason Grade Group V patients treated with radical prostatectomy or external beam radiation therapy: 4+5 vs. 5+4 vs. 5+5 (2021) (0)
Comparison of early salvage and adjuvant radiotherapy for non-organ-confined prostate cancer after radical prostatectomy (2020) (0)
Local Treatment in the Management of Oligometastatic Prostate Cancer (2018) (0)
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy (2022) (0)
988 DETECTION OF CEACAM1 AND CEA IN URINE SAMPLES OF PROSTATE CANCER PATIENTS (2011) (0)
MP72-17 IMPACT OF PRIMARY GLEASON PATTERN ON RESULTS OF EARLY SALVAGE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY (2019) (0)
1904 EXTRANODAL EXTENSION IS A POWERFUL PROGNOSTIC FACTOR IN BLADDER CANCER PATIENTS WITH LYMPH NODE METASTASIS (2012) (0)
Are the results of the ProtecT trial applicable to contemporary prostate cancer patients treated at two high-volume European Institutions? (2017) (0)
MP60-09 EFFECT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON ONCOLOGIC OUTCOMES IN D’AMICO INTERMEDIATE- AND HIGH-RISK RADICAL PROSTATECTOMY PATIENTS (2018) (0)
IMPACT OF REVERSE STAGE MIGRATION ON THE OUTCOME OF NODE POSITIVE PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A LARGE, TWO‐CENTER EXPERIENCE: MP97‐07 (2017) (0)
Long-term taxane exposure and transdifferentiation of prostate cancer in vitro. (2023) (0)
MP50-03 SALVAGE RADICAL PROSTATECTOMY COMPLICATIONS AND FUNCTIONAL OUTCOMES: OPEN VERSUS ROBOTIC PROCEDURES. (2016) (0)
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages (2020) (0)
Grade and stage misclassification in unfavorable intermediate vs high-risk NCCC prostate cancer candidates for RT plus short vs long-term androgen ADT (2022) (0)
Reply to Pablo Sierra's Letter to the Editor re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.01.048. (2019) (0)
836 A PROSPECTIVE SINGLE-CENTER STUDY TO EVALUATE 18F-FLUORODEOXYGLUCOSE PET/CT IN STAGING PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA (2011) (0)
ANTIMICROBIAL LUBRICANT REDUCES RECTAL BACTERIA AT TRANSRECTAL PROSTATE BIOPSY. RESULTS FROM A LARGE PROSPECTIVE RANDOMIZED TRIAL: MP77‐06 (2017) (0)
Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial. (2019) (0)
The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer (2021) (0)
1043 Impact of synchronous metastasis distribution on survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy (2014) (0)
Analysis of small non-coding RNAs in urinary exosomes accurately classifies prostate cancer into low grade (GG1) and higher grade (GG2-5) (2020) (0)
Impact of primary Gleason pattern on results of early salvage radiotherapy after radical prostatectomy (2019) (0)
MP78-18 IMPACT OF CAPSULAR INCISION DURING RADICAL PROSTATECTOMY ON BIOCHEMICAL RECURRENCE RATES (2015) (0)
Incidence, risk factors, management and complications of rectal injuries during radical prostatectomy (2017) (0)
UP-01.036 Urinary Protein Patterns Discriminate Bladder Cancer Patients from Healthy Subjects (2011) (0)
External validation of the Mayo Clinic Stage, Size, Grade, and Necrosis score in patients with renal cell carcinoma and venous tumor thrombus (2017) (0)
Kontrastmitttel for ultrasound examination of the prostate and method for diagnosing prostate cancer (2007) (0)
Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis (2020) (0)
MP15-16 VALIDATION OF EAU RECOMMENDATION FOR SALVAGE RADICAL PROSTATECTOMY CANDIDATES (2022) (0)
530 EXTERNAL VALIDATION OF DISEASE-FREE SURVIVAL AT 2 OR 3 YEARS AS A SURROGATE AND NEW PRIMARY ENDPOINT FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER OF THE BLADDER (2012) (0)
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis. (2022) (0)
PD43-07 IMPACT OF POSITIVE SURGICAL MARGIN LENGTH AND GLEASON GRADE AT THE MARGIN ON ONCOLOGIC OUTCOMES IN PATIENTS WITH NON-ORGAN-CONFINED PROSTATE CANCER (2020) (0)
808 The impact of not determinable surgical margins after radical prostatectomy (2015) (0)
PD34-10 ATTRACTIVENESS AND ACCESSIBILITY OF FOCAL THERAPY FOR PROSTATE CANCER: RESULTS OF AN INTERNATIONAL WEB-BASED SURVEY (2018) (0)
PD17-08 COMPARING THE DIAGNOSTIC ACCURACY OF 68GA-PSMA AND 11C-CHOLINE PET/CTSCAN ACCORDING TO PSA LEVEL: A LARGE MULTI-INSTITUTIONAL ANALYSIS WITH HISTOLOGICAL VERIFICATION IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER (2019) (0)
[Established and upcoming new options in medical therapy for benign prostatic hyperplasia]. (2009) (0)
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab (2011) (0)
Refining patient selection for salvage radical prostatectomy: Oncological outcomes compared between EAU guidelines-compliant and non-compliant patients (2020) (0)
Editorial Comment. (2019) (0)
Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma. (2022) (0)
125 DETECTION OF CEACAM1 AND CEA IN URINE SAMPLES OF PROSTATE CANCER PATIENTS (2011) (0)
PD27-05 IMPACT OF PERITONEAL BLADDER FLAP ON THE RISK OF SYMPTOMATIC LYMPHOCELES AFTER ROBOTIC RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE RANDOMISED-CONTROLLED TRIAL (2023) (0)
Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.02.009. (2020) (0)
Comparing the diagnostic accuracy of 68Ga-PSMA and 11C-Choline PET/CT scan according to PSA level: A large multi-institutional analysis with histological verification in patients treated with salvage lymph node dissection for recurrent prostate cancer (2019) (0)
EAU patient selection criteria are predictors of metastasis-free survival in a large contemporary salvage radical prostatectomy patients cohort (2023) (0)
68GaPSMA-11 PET/CT to monitor treatment response in patients with metastatic prostate cancer: The concordance between biochemical response and PSMA response. (2023) (0)
PD40-06 A COMPARATIVE STUDY OF ROBOT-ASSISTED LAPAROSCOPIC AND OPEN RETROPUBIC RADICAL PROSTATECTOMY IN 10,790 MEN TREATED BY HIGHLY TRAINED SURGEONS FOR BOTH PROCEDURES – THE MARTINI-KLINIK EXPERIENCE (2019) (0)
Contemporary conditional cancer‐specific survival rates in surgically treated adrenocortical carcinoma patients: A stage‐specific analysis (2022) (0)
Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal approach (2020) (0)
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis. (2022) (0)
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States. (2023) (0)
1401 IS THE NODAL YIELD ASSOCIATED WITH OUTCOMES IN BLADDER CANCER PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY (2012) (0)
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma (2022) (0)
78 NEOADJUVANT ANTI-ANGIOGENIC TREATMENT OF RENAL CELL CANCER AND ITS EFFECT ON TUMOR BLOOD VESSELS (2010) (0)
CHD1 deletion is an independent predictor of poor prognosis by increased metastasis in both PTEN-deficient and -intact prostate cancer (2018) (0)
Impact of bilateral neurovascular bundle preservation on oncological outcomes in non-organ confined prostate cancer patients (2019) (0)
MP66-14 PSA PERSISTENCE AFTER RADICAL PROSTATECTOMY AND ITS IMPACT ON ONCOLOGIC OUTCOMES (2019) (0)
PD42-07 RADICAL VS PARTIAL CYSTECTOMY FOR URACHAL CARCINOMA: A POPULATION-BASED ANALYSIS (2022) (0)
Impact of adjuvant radiotherapy in patients with high burden lymph node metastases after radical prostatectomy (2020) (0)
IMPACT OF ADDITIONAL RADIATION AND/OR ADT ON FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: MP47‐03 (2017) (0)
1024 TUMOUR VESSEL REMODELLING IN RENAL CELL CARCINOMA AFTER NEOADJUVANT ANTI-ANGIOGENIC TREATMENT (2009) (0)
What is the optimal management of nodal oligorecurrent prostate cancer? Results from a large series of patients treated with salvage lymph node dissection (2022) (0)
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease Volume. (2023) (0)
1898 CLINICAL CARCINOMA IN SITU ONLY DISEASE: OUTCOMES OF PATIENTS TREATED WITH RADICAL CYSTECTOMY (2011) (0)
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis. (2021) (0)
1892 PT2 SUBSTAGING IN UROTHELIAL CARCINOMA OF THE BLADDER: DEEP MUSCLE INVASION IS ASSOCIATED WITH WORSE OUTCOME (2011) (0)
548 IDENTIFICATION OF DEREGULATED PATHWAYS IN PENILE CANCER USING GENE SET ENRICHMENT ANALYSIS (GSEA) – A PILOT STUDY (2010) (0)
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype (2022) (0)
MP79-02 PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION (2020) (0)
Oncologic outcomes after radical prostatectomy for high risk prostate cancer: Impact of various definitions on cancer-specific and overall mortality (2019) (0)
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients (2018) (0)
PD27-03 NERVE-SPARING RADICAL PROSTATECTOMY (NSRP) USING THE NEUROSAFE TECHNIQUE IS ONCOLOGICALLY SAFE: RESULTS AFTER 20 YEARS OF EXPERIENCE (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Derya Tilki?

Derya Tilki is affiliated with the following schools:

Ludwig Maximilian University of Munich
Koç University
University of California, Davis

Derya Tilki's Academic­Influence.com Rankings

Why Is Derya Tilki Influential?

Derya Tilki's Published Works

Published Works

What Schools Are Affiliated With Derya Tilki?

Derya Tilki's AcademicInfluence.com Rankings